Compound
Well-known member
I'm seeing a disturbing trend: patients who *refuse* to discontinue their GLP-1s.
https://www.statnews.com
An endocrinologist describes the issue:
Some patients are begging to stay on the drugs longer than medically advisable, creating an ethical grey area.
He categorizes patients:
* Most lose 10-20% and maintain it on treatment.
* 5% don't respond or can't tolerate it.
* 5% are "super responders" losing upwards of 25%.
He struggles with patients who want *more* loss, or who have lost *too much*, and resist stopping or lowering the dose, even with unhealthy eating behaviors, muscle loss, or strained relationships.
He uses metrics like cholesterol, blood pressure, and reported diet/exercise to guide decisions, avoiding numeric weight loss goals from the start. It's a tough situation.
https://www.statnews.com
An endocrinologist describes the issue:
Some patients are begging to stay on the drugs longer than medically advisable, creating an ethical grey area.
He categorizes patients:
* Most lose 10-20% and maintain it on treatment.
* 5% don't respond or can't tolerate it.
* 5% are "super responders" losing upwards of 25%.
He struggles with patients who want *more* loss, or who have lost *too much*, and resist stopping or lowering the dose, even with unhealthy eating behaviors, muscle loss, or strained relationships.
He uses metrics like cholesterol, blood pressure, and reported diet/exercise to guide decisions, avoiding numeric weight loss goals from the start. It's a tough situation.